The effect of enhancer on the penetration of oxybutynin chloride via transdermal drug delivery

Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 4-6, 2008, Pages 666-670

  Kim, Yun Tae ^a   Jeong, Jae Su ^a   Oh, A Young ^a   Lee, Jun Hee ^a   Ahn, Sik Il ^a   Park, Jong Hak ^a   Kim, Won ^a   Kim, Dae Sung ^a   Lee, Han Koo ^b   Khang, Gilson ^a  

^a Chonbuk National University   (South Korea)

^b Daehwa Pharm Co Ltd   (South Korea)

Author keywords

Enhancer; Oxybutynin chloride; Permeability; Transdermal

Indexed keywords

ENHANCER; LONG-CHAIN FATTY ACIDS; OXYBUTYNIN; PENETRATION ENHANCERS; SHORT-CHAIN FATTY ACIDS; TRANSDERMAL; TRANSDERMAL DRUG DELIVERY; TRANSDERMAL THERAPEUTIC SYSTEMS;

CHAINS; FATTY ACIDS; MECHANICAL PERMEABILITY;

CHLORINE COMPOUNDS;

EID: 77950857629     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Z Khan, J Hertanu, WC Yang, et al., Predictive correlation of uroynamic dysfunction and brain injury after cerebovascular accident, J Urol, 126(1), 86 (1981).
2. JH Lee, W Kim, DS Kim, et al., Development and clinical application of nanoparticles, Tissue Eng Regen Med, 5(3), 404 (2008).
3. CR Lee, MS Kim, G Khang, et al., Pressure-sensitive adhesives for transdermal drug delivery system, Tissue Eng Regen Med, 3(2), 85 (2006).
4. G Khang, H Seong, HB Lee, Sustained delivery of drugs with biodegradable polymers, In Advanced in Biomaterials and Drug Delivery Systems, Edited by G-H Hsuie, T Okano, YU Kim, H-W Sung, N Yui, KD Park, Princeton Inter. Pub Co Ltd, Taipei, Taiwan, 537 (2002).
5. JH Mo, MS Kim, G Khang, et al., Transdermal microneedle for drug delivery applications, Tissue Eng Regen Med, 4(2), 174 (2007).
6. G Khang, HS Choi, JM Rhee, et al., Controlled release of gentamicin sulfate from PHBV wafers for the treatment of osteomyelitis, Polymer(Korea), 8(6), 253 (2000).
7. JH Mo, MJ Kim, YT Kim, et al., The overcome of skin barrier for transdermal drug delivery system, Tissue Eng Regen Med, 4(4), 525 (2007).
8. JH Moh, MJ Kim, YT Kim, et al., Recent advances of optimizing transdermal drug delivery through diffusion modeling, Tissue Eng Regen Med, 5(1), 57 (2008).
9. JH Mo, MJ Kim, YT Kim, et al., Recent advances of optimizing transdermal drug delivery through diffusion modeling, Tissue Eng Regen Med, 5(1), 57 (2008).
10. JS Park, JH Lee, HS Shin, et al., Microemulsions as carriers for drugs and nutraceuticals, Tissue Eng Regen Med, 4(4), 502 (2007).
11. JS Park, JH Lee, HS Shin, et al., Biodegradable polymer microspheres for controlled drug release, Tissue Eng Regen Med, 4(3), 347 (2007).
12. E Touitou, Drug delivery across the skin, Expert Opin Biol Ther, 2, 723 (2002).
13. S Nicoli, E Penna, C Padula et al., New transdermal bioadhesive film containing oxybutynin: in vitro permeation across rabbit ear skin, Int J Pharm, 325, 2 (2001).
14. D Rolf, Chemical and physical methods of enhancing transdermal drug delivery, Pharm Technol, 130 (1998).
15. O Wong, Iontophoresis, Fundamentals: In drug permeation enhancement, DS Hsieh(ed.), Marcel Dekker, New York, pp 219 (1994).
16. DM Skauin, GM Zentner, Phonophoresis, Int J Pharm, 20, 230 (1984).
17. EM Niazy, Influence of oleic acid and other permeation promoters on transdermal delivery of dihydroergotamine through rabbit skin, Int J Pharm, 67, 97 (1990).
18. T Ogiso, M Shintani, Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propanol, J Pharm Sci, 79(12), 1065 (1990).
19. M Yamada, Y Uda, Y Tanigawara, Mechanism of enhancement of percutaneous absorption of molsidomine by oleic acid, Chem Pharm Bull, 35(8), 3399 (1987).
20. Y Obata, K Takayama, H Okabe, et al., Effect of cyclic monoterpenes on percutaneoue absorption in the case of a water soluble drug (diclofenac sodium), Drug Dev Ind Pharm, 6(4), 319 (1990).
21. K Takayama, T Nagai, Limonene and related compounds as potential skin penetration promoters, Drug Dev Ind Pharm, 20, 677 (1994).
22. M Hori, S Satoh, Hi Maibach, et al., Enhancement of potential skin penetration pronoters, J Pharm Sci, 80(1), 32 (1991).
23. CS Leopold and BC Lippold, An attempt to clarify the mechanism of the penetration enhancing effects of lipophilic vehicles with differential scanning calorimetry(DSC), Pharm Res, 10, 245 (1993).
24. BM Elyan, MB sidhom, FM Plakogiannis, Evaluation of the Effect of Different Fatty Acids on the Percutaneous Absorption of Metaproterenol Sulfate, J Pharm Sci, 85, 101 (1996).
25. GM Golden, JE Mckie, RO Potts, Role of stratum corneum lipid fluidity in transdermal drug flux, J Pharm Sci, 76, 25 (1987).
26. PG Green, RH Guy, J Hadgraft, in vitro and In vivo enhancement of skin permeation with oleic and lauric acids, Int J Pharm, 48, 103 (1988).
27. D Kobayashi, T Matsuzawa, K Sugivayashi, et al., Feasibility of use of several cardiovascular agent in transdermal therapeutic systems with 1-menthol-ethanol system on hairless rat and human skin, Biol Pharm Bull, 16, 254 (1993).
28. H Okabe, K Takayama, T nagai, Percutaneous absorption of ketoprofen from acrylic gel patches containing d-limonene and ethanol as absorption enhancers, Chem Pharm Bull, 40, 1906 (1992).
29. M. Hori, S Satoh, HI Maibach, et al., Enhancement of propranol hydrochloride and diazepam skin absorption in vitro: effect of enhan cer lipophilicity, J Pharm Sci, 80, 32 (1991).
30. H Sezaki, H Okamoto, M Hashida, Structure-activity relationship of 1-alkyl- or 1-alkenylazacycloalkanone derivatives as percutaneous penetration enhancers, J Pharm Sci, 77, 418 (1988).